← 홈

ADC · HER2+ 유방암

281개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 281개
ADCBiologicstaleBoehringer IngelheimPhase 2

Zongertinib (Zongertinib)

Metastatic Breast Cancer; Metastatic Gastric Adenocarcinoma · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 15상태 RECRUITING
ADCBiologicstaleMedSIRPhase 2

CDK4/6i plus ET (CDK4/6i plus ET)

Advanced Breast Cancer; Advanced Breast Carcinoma · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 19.3%임상시험 14상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

Camizestrant (Camizestrant)

Ovarian Cancer; Breast Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 15.7%임상시험 14상태 RECRUITING
ADCBiologicAstraZenecaalonePhase 2

saruparib (AZD8205 and AZD5305, AZD8205 and AZD5305 (saruparib))

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 13상태 RECRUITING
ADCBiologicAstraZenecaalonePhase 2

AZD8205 and AZD5305 (AZD8205 and AZD5305, AZD8205 and AZD5305 (saruparib) and AZD2936 (rilvegostomig), saruparib)

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 13상태 RECRUITING
ADCBiologicstaleCelldex TherapeuticsPhase 2

CDX-011 (CDX-011)

Breast Cancer · Metastatic gpNMB Over-expressing Triple

#MetastaticgpNMBOver-expressingTr#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 21%임상시험 13상태 ACTIVE
ADCBiologicstaleBayerPhase 2

Copanlisib Hydrochloride (Copanlisib Hydrochloride)

Breast Adenocarcinoma; Metastatic Breast Carcinoma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 38.5%임상시험 13상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Z-endoxifen (Z-endoxifen)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 13상태 RECRUITING
ADCBiologicstaleAmbrx, Inc.Phase 3

ARX788 (ARX788)

HER2-positive, Metastatic Breast Cancer · Breast Neoplasms

#BreastNeoplasms#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 12상태 RECRUITING
ADCBiologicstaleShanghai Miracogen Inc.Phase 3

MRG002 (MRG002)

Advanced Breast Cancer; Metastatic Breast Cancer · Advanced or Metastatic Biliary Tract Can

#AdvancedorMetastaticBiliaryTract#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 12상태 ACTIVE
ADCBiologicstaleSuzhou Suncadia Biopharmaceutic…Phase 2

SHR-A2009 (SHR-A2009)

Advanced Breast Cancer; Metastatic Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 12상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

durvalumab (Imfinzi, Datopotamab deruxtecan + Durvalumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 56.5%임상시험 11상태 RECRUITING
ADCBiologicstaleShanghai JMT-Bio Inc.Phase 3

JSKN003 (JSKN003)

Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 11상태 RECRUITING
ADCBiologicstaleRochePhase 1

ado-trastuzumab emtansine (Kadcyla, T-DM1, PD-0332991 and T-DM1)

Advanced Breast Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 11상태 ACTIVE
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48 + Carboplatin)

Ovarian Cancer; HER2 · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 11상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

Zilovertamab vedotin (Zilovertamab vedotin)

Lymphoma, Large B-Cell, Diffuse · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 1.4%임상시험 10상태 DISCONTINUED
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Amcenestrant (Amcenestrant)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 42.3%임상시험 9상태 RECRUITING
ADCBiologicstaleCSPC ZhongQi Pharmaceutical Tec…Phase 3

DP303c (DP303c)

HER2-positive Breast Cancer · Localized Advanced or Metastatic Gastric

#LocalizedAdvancedorMetastaticGas#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 9상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Lasofoxifene (Lasofoxifene)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 9상태 RECRUITING
ADCBiologicstaleCelldex TherapeuticsPreclinical

glembatumumab vedotin (glembatumumab vedotin)

Metastatic gpNMB Expressing Triple Negative Breast Cancer · Melanoma

#Melanoma#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 21%임상시험 9상태 ACTIVE

8 / 15 페이지

← 이전다음 →